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OBSTETRICS
Congenital syphilis: trends in mortality and morbidity
in the United States, 1999 through 2013
John R. Su, MD, PhD, MPH1; Lesley C. Brooks, MD1; Darlene W. Davis; Elizabeth A. Torrone, PhD;
Hillard S. Weinstock, MD, MPH; Mary L. Kamb, MD, MPH
BACKGROUND: Congenital syphilis (CS) results when an infected
pregnant mother transmits syphilis to her unborn child prior to or at
delivery. The severity of infection can range from a delivery at term without
signs of infection to stillbirth or death after delivery.
OBJECTIVE: We sought to describe CS morbidity and mortality during
1999 through 2013.
STUDY DESIGN: National CS case data reported to Centers for
Disease Control and Prevention during 1999 through 2013 were analyzed.
Cases were classified as dead (stillbirths and deaths up to 12 months after
delivery), morbid (cases with strong [physical, radiographic, and/or non-
serologic laboratory] evidence of CS), and nonmorbid (cases with a normal
physical examination reported, without strong evidence of infection).
Annual rates of these cases were calculated. Cases were compared using
selected maternal and infant criteria.
RESULTS: During 1999 through 2013, 6383 cases of CS were reported:
6.5% dead, 33.6% morbid, 53.9% nonmorbid, and 5.9% unknown
morbidity; 81.8% of dead cases were stillbirths. Rates of dead, morbid, and
nonmorbid cases all decreased over this time period, but the overall
proportions that were dead ormorbid cases did not significantly change. The
overall case fatality ratio during 1999 through 2013 was 6.5%. Among
cases of CS, maternal race/ethnicity was not associated with increased
morbidity or death, although most cases (83%) occurred among black or
Hispanic mothers. No or inadequate treatment for maternal syphilis, <10
prenatal visits, and maternal nontreponemal titer 1:8 increased the like-
lihood of a dead case; risk of a dead case increased with maternal non-
treponemal titer (c2 for trend P< .001). Infants with CS born alive at<28
weeks’ gestation (relative risk, 107.4; P< .001) or born weighing<1500 g
(relative risk, 43.9; P < .001) were at greatly increased risk of death.
CONCLUSION: CS remains an important preventable cause of peri-
natal morbidity and mortality, with comparable case fatality ratios during
1999 through 2013 (6.5%) and 1992 through 1998 (6.4%). Detection and
treatment of syphilis early during pregnancy remain crucial to reducing CS
morbidity and mortality.
Key words: congenital syphilis, infant mortality, prenatal care, sexually
transmitted disease surveillance, stillbirth
Introduction
Congenital syphilis (CS) is the trans-
mission of syphilis from an infected
mother to her infant at or prior to de-
livery. Syphilis that is untreated or
treated late in gestation can lead to CS
in >50% of affected pregnancies,1,2
resulting in stillbirth, neonatal death,
or other morbidity, including visceral or
neurologic damage in surviving infants.
CS is preventable if syphilis in the
mother is treated early in pregnancy
with penicillin,3 and prenatal syphilis
screening and treatment are effective
interventions.4 Because CS is related to
both community prevalence of syphilis
among reproductive-aged women and
prenatal intervention, CS case rates
reflect a health system’s effectiveness.
Effective prevention of CS in the
United States is challenging. Diagnosis
remains difficult, and lack of provider
awareness about CS still exists.5 Social
determinants of health and health sys-
tems’ issues affect access to and quality
of prenatal care. Many of these issues
affect racial/ethnic minority women,6-8
leading to disparities in diseases,9-13
including syphilis and CS.14
A previous analysis by Gust et al15
reviewed national case report data dur-
ing 1992 through 1998, following a revi-
sion to the CS surveillance case definition
that increased sensitivity to increase
treatment among affected infants. The
analysis of Gust et al15 showed declines in
both overall cases of CS and cases of CS
that died, with no decline in the propor-
tion of CS cases that died. Here, we
describe trends inCS infantmortality and
morbidity during 1999 through2013, and
associated maternal and infant factors.
Materials and Methods
Case data for CS are reported to local
and state health departments; states
voluntarily transmit that data to the
Centers for Disease Control and Pre-
vention (CDC). We reviewed CS case
data from all 50 states and Washington,
DC, reported to CDC as of Aug. 1, 2014,
for cases born during 1999 through 2013;
cases were reported based on the sur-
veillance case definition for CS used
during this time period.14 Cases were
classified by disease severity. A dead case
was defined as a case of CS that died,
either as a stillbirth or as a live birth that
died within 12 months of delivery. A
morbid case was defined as a case of CS
reported as alive, with strong evidence of
infection based on 1 of the following
situations: (1) findings on darkfield mi-
croscopy or direct fluorescent antibody
examination of lesions (on the infant),
placenta, or umbilical cord consistent
with syphilis, a reactive cerebrospinal
fluid (CSF) Venereal Disease Research
Laboratory test, or changes on long
bone radiographs consistent with syph-
ilis; (2) physical signs or symptoms
of syphilis (hepatosplenomegaly, rash,
condyloma lata, snuffles, jaundice
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[nonviral hepatitis], pseudoparalysis,
anemia, edema [nephrotic syndrome
and/or malnutrition]); or (3) an elevated
CSF white blood cell count (WBC) and/
or CSF protein concentration absent
other causes, and the case’s mother was
not treated or inadequately treated for
syphilis (“adequate” defined as penicillin
therapy appropriate for maternal stage of
infection, administered 30 days before
delivery). A nonmorbid case was defined
as a case of CS reported as alive, without
the strong evidence of infection described
for a morbid case (either because such
tests or procedures were negative or not
performed), who had a normal physical
examination reported. A case of un-
knownmorbidity was defined as a case of
CS reported as alive, without the strong
evidence of infection described for a
morbid case (either because such tests or
procedures were negative or not per-
formed), and without a normal physical
examination reported. To understand
how testing (or lack of it) influenced case
classification, the number of morbid and
nonmorbid cases with CSF testing (CSF
protein, WBC count, and/or CSF Ve-
nereal Disease Research Laboratory test)
and long bone radiographic examination
were calculated.
Annual rates of dead, morbid, and
nonmorbid cases of CS were calculated
with the annual count of dead, morbid,
or nonmorbid cases of CS as the
numerator and live births for the corre-
sponding year as the denominator, using
natality data matched for maternal race/
ethnicity. Population denominators for
2012 (the most recent data available at
time of analysis) were used to calculate
rates for 2013.
Cases of CS (dead, morbid, non-
morbid, and unknown) were described
by maternal and infant characteristics.
Maternal characteristics analyzed were
age (<25 or 25 years); marital status
(married; single, never married;
separated/divorced; or other); race/
ethnicity (black, Hispanic, white,
Asian/Pacific Islander, Native Amer-
ican/Alaska Native, or other); census
region (Midwest, Northeast, South,
or West); number of prenatal care
visits (none, 1e4, 5e9, or 10 visits);
trimester of first prenatal visit (first,
second, or third trimester); treatment
for syphilis (adequate or inadequate);
and nontreponemal titer closest to
delivery (1:4, 1:8e1:32, 1:64e1:256,
or >1:256). Infant characteristics
analyzed were gestational age at time
of delivery (<28, 28e31, 32e36, or
37 weeks) and birthweight (<1500,
1500-2499, or 2500 g); because pre-
maturity and low birthweight are
common among stillbirths,16 analysis
of gestational age and birthweight was
limited to cases of CS that were born
alive. Race/ethnicity was defined using
the National Center for Health Statis-
tics bridged-race categories,17 while US
regions were defined using the US
Census geographic regions.
A c2 test for linear trend was used to
determine if significant overall trends in
proportions of deadormorbid cases ofCS
were present during 1999 through 2013.
To determine if maternal or infant char-
acteristics were associated with negative
outcomes (a morbid or dead case), rela-
tive risks (RR) and 95% confidence in-
tervals (CIs) were calculated, comparing
morbid cases and dead cases as a group to
nonmorbid cases. To determine if
maternal or infant characteristics were
associatedwith themost extremenegative
outcome (ie, death), RR and 95% CIs
were calculated, comparing dead cases to
morbid cases and nonmorbid cases as a
group. A sensitivity analysis was per-
formed to explore how missing informa-
tion (ie, cases classified as unknown
morbidity) might affect these analyses:
RR and 95%CIs were also calculatedwith
cases of unknown morbidity reclassified
as: (1) all nonmorbid cases, and (2) all
morbid cases. Data were analyzed using
software (SAS, Version 9.3; SAS Institute
Inc, Cary, NC). CS data were collected as
part of routine public health surveillance
and were thus exempt from institutional
review board review.
Results
During 1999 through 2013, a total of
6383 cases of CS were reported to CDC,
with the highest proportions among
black or Hispanic mothers; single, never-
married mothers; and mothers in
the South (Table 1): 6.5% dead, 33.6%
morbid, 53.9% nonmorbid, and 5.9% of
unknownmorbidity. Of the 2145morbid
cases, 1960 (91.4%) had some combina-
tion of CSF testing (CSF protein, WBC,
and/or CSF Venereal Disease Research
Laboratory test) and/or long bone
radiographic examination, with 1197
(61.1%) having both tests performed. Of
the 3443 nonmorbid cases, 511 (14.8%)
had both CSF testing and long bone
radiographic examination performed.
Dead cases, overall case fatality
ratio, and neonatal mortality rate
Of the 418 dead cases of CS reported
during 1999 through 2013, 342 (81.8%)
were stillbirths, 70 died <28 days after
delivery (ie, were neonatal deaths), and 6
died 1-12 months after birth. Of the 70
neonatal deaths, 29 were within 1 day of
birth, 23 between 2-7 days after birth,
and 18 between 8-27 days after birth.
The overall case fatality ratio was 6.5%
(418 deaths among 6383 cases of CS);
overall neonatal mortality among re-
ported cases of CS was 11.6 per 1000 live
births (70 neonatal deaths per 6041 live-
born cases of CS).
Trends in rates of dead, morbid, and
nonmorbid cases of CS
Overall, rates of dead, morbid, and
nonmorbid cases of CS all declined
during 1999 through 2013 (Figure 1).
The rate of dead cases declined slightly
and very gradually throughout 1999
through 2013, while rates of morbid and
nonmorbid cases declined the most
during 1999 through 2005. Dead cases
comprised a median of 6.5% (range
4.7e9.0%) cases of CS annually. Morbid
cases comprised a median of 34.7%
(range 25.3e38.9%) cases of CS annu-
ally. No significant overall trends in
proportions of either dead or morbid
cases of CS were observed.
During 1999 through 2013, 5989
(94%) cases of CS occurred among
black, Hispanic, and white mothers.
Rates for dead cases of CS among
black mothers and Hispanic mothers
decreased during this time period, but
remained relatively unchanged among
white mothers (Figure 2). In 2013, the
rate of dead, morbid, and nonmorbid
cases of CS among black mothers was
7.5, 9.0, and 12.7 times the rate among
Original Research OBSTETRICS ajog.org
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TABLE 1
Selected demographic and clinical characteristics of infants with congenital syphilis and their mothers,
by severity of illnesseUnited States, 1999 through 2013
Dead (%) Morbid (%) Nonmorbid (%) Unknown (%) Total (%)
n ¼ 418 n ¼ 2145 n ¼ 3443 n ¼ 377 N ¼ 6383
Maternal characteristicsedemographics
Maternal age, y
25 188 (45) 1176 (55) 1981 (58) 222 (59) 3567 (56)
24 228 (55) 954 (44) 1424 (41) 146 (39) 2752 (43)
Blank 2 (0) 15 (1) 38 (1) 9 (2) 64 (1)
Marital status
Married 41 (10) 298 (14) 574 (17) 59 (16) 972 (15)
Single, never married 310 (74) 1506 (70) 2328 (68) 230 (61) 4374 (69)
Separated/divorced 8 (2) 80 (4) 91 (3) 11 (3) 190 (3)
Other 1 (0) 8 (0) 18 (1) 7 (2) 34 (1)
Unknown/missing 58 (14) 253 (12) 432 (13) 70 (19) 813 (13)
Race/ethnicity
White 38 (9) 262 (12) 377 (11) 47 (12) 724 (11)
Black 218 (52) 1125 (52) 1749 (51) 211 (56) 3303 (52)
Hispanic 141 (34) 642 (30) 1083 (31) 96 (25) 1962 (31)
Asian/Pacific Islander 7 (2) 46 (2) 95 (3) 7 (2) 155 (2)
American Indian/Alaska Native 5 (1) 26 (1) 33 (1) 3 (1) 67 (1)
Other 1 (0) 9 (0) 27 (1) 4 (1) 41 (1)
Unknown 8 (2) 35 (2) 79 (2) 9 (2) 131 (2)
Regiona
Midwest 75 (18) 306 (14) 437 (13) 106 (28) 924 (14)
Northeast 30 (7) 253 (12) 394 (11) 13 (3) 690 (11)
South 213 (51) 1083 (50) 1812 (53) 207 (55) 3315 (52)
West 100 (24) 503 (23) 800 (23) 51 (14) 1454 (23)
Maternal characteristicsedetection of maternal syphilis
Prenatal visits, no.
0/No prenatal care 199 (48) 690 (32) 794 (23) 100 (27) 1783 (28)
1e4 84 (20) 377 (18) 551 (16) 52 (14) 1064 (17)
5e9 39 (9) 335 (16) 570 (17) 42 (11) 986 (15)
10 18 (4) 284 (13) 583 (17) 37 (10) 922 (14)
Unknown 78 (19) 459 (21) 945 (27) 146 (39) 1628 (26)
Prenatal visits, trimester
No prenatal care 199 (48) 690 (32) 794 (23) 100 (27) 1783 (28)
First 75 (18) 472 (22) 830 (24) 63 (17) 1440 (23)
Second 68 (16) 355 (17) 680 (20) 55 (15) 1158 (18)
Third 11 (3) 253 (12) 399 (12) 27 (7) 690 (11)
Unknown 65 (16) 375 (17) 740 (21) 132 (35) 1312 (21)
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white mothers, respectively; the rate of
dead, morbid, and nonmorbid cases of
CS among Hispanic mothers was 4.5,
3.5, and 2.9 times the rate among white
mothers, respectively. Despite these
racial/ethnic disparities, black mothers
and Hispanic mothers of cases of CS
were no more likely to bear dead or
morbid cases of CS than white mothers
of cases of CS (Table 2).
Maternal characteristics and risk of
infant morbidity and mortality
Maternal characteristics associated with
risk of morbidity and mortality from CS
included number of prenatal care visits,
adequacy of treatment, and non-
treponemal titer (Table 2). Compared
to mothers with 10 prenatal visits,
mothers with fewer visits were more
likely to bear a morbid or dead case.
The likelihood of bearing a dead case
increased as prenatal visits decreased (c2
for trend P < .001); this trend remained
significant after limiting consideration to
dead cases that were live-born but later
died (eg, no stillbirths) (data not
shown). Compared to mothers receiving
adequate treatment (penicillin appro-
priate for stage of infection, adminis-
tered30 days before delivery), mothers
TABLE 1
Selected demographic and clinical characteristics of infants with congenital syphilis and their mothers,
by severity of illnesseUnited States, 1999 through 2013 (continued)
Dead (%) Morbid (%) Nonmorbid (%) Unknown (%) Total (%)
n ¼ 418 n ¼ 2145 n ¼ 3443 n ¼ 377 N ¼ 6383
Maternal characteristicsetreatment and nontreponemal titers
Treatmentb
None 304 (73) 1433 (67) 1814 (53) 255 (68) 3844 (60)
Adequate 17 (4) 82 (4) 684 (20) 34 (9) 809 (13)
Inadequate 67 (16) 630 (29) 916 (27) 86 (23) 1697 (27)
Unknown 30 (7) 0 (0) 29 (1) 2 (1) 33 (1)
Nontreponemal titerc
1:4 45 (11) 553 (26) 1273 (37) 127 (34) 1998 (31)
1:8e1:32 146 (35) 844 (39) 1426 (41) 144 (38) 2560 (40)
1:64e1:256 200 (48) 660 (31) 587 (17) 78 (21) 1525 (24)
>1:256 25 (6) 76 (4) 123 (4) 21 (6) 245 (4)
Unknown 2 (0) 12 (1) 34 (1) 7 (2) 55 (1)
Infant characteristics
Gestational age at birth, wk
37 43 (10) 1353 (63) 2504 (73) 202 (54) 4102 (64)
32e36 103 (25) 535 (25) 542 (16) 71 (19) 1251 (20)
28e31 114 (27) 117 (5) 81 (2) 12 (3) 324 (5)
<28 132 (32) 37 (2) 56 (2) 8 (2) 233 (4)
Unknown 26 (6) 103 (5) 260 (8) 84 (22) 473 (7)
Birthweight, g
2500 45 (11) 1408 (66) 2592 (75) 218 (58) 4263 (67)
1500e2499 111 (27) 528 (25) 513 (15) 65 (17) 1217 (19)
<1500 164 (39) 116 (5) 125 (4) 18 (5) 423 (7)
Unknown 98 (23) 93 (4) 213 (6) 76 (20) 480 (8)
In descending order of severity: stillborn infants and infants who died up to 12 mo after birth (dead); infants with strong evidence of syphilis, based on testing indicative of syphilis, physical signs or
symptoms of syphilis, and/or (in mother untreated or inadequately treated for syphilis) elevated cerebrospinal fluid (CSF) white blood cell count or CSF protein concentration absent other causes (see
“Materials and Methods”) (morbid); infants lacking evidence of infection present in morbid cases, with normal physical examination reported (nonmorbid); and infants lacking evidence of infection
present in morbid cases, without normal physical examination reported (unknown).
a US regions as defined by Census Bureau; b “Adequate” treatment was defined as penicillin treatment appropriate for mother’s stage of infection administered 30 d before delivery; c Non-
treponemal titer nearest to delivery.
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receiving inadequate treatment or no
treatment were more likely to bear
a morbid or dead case. Compared to
mothers with a nontreponemal titer
of1:4, mothers with titers of1:8 were
more likely to bear a morbid or dead
case. The likelihood of bearing a morbid
or dead case increased with titer (c2 for
trend P < .001).
Infant characteristics associated
with mortality
Most infants with CS (64%) were born
at 37 weeks’ gestation (Table 1); most
infants (67%) were born weighing
2500 g. Because prematurity and low
birthweight are common among still-
births,16 birthweights and gestational
ages of dead cases that were not still-
births (ie, that were born alive but later
died), morbid cases, and nonmorbid
cases were compared (Table 2).
Compared to infants born at37 weeks’
gestation, infants born at 36 weeks’
gestation were more likely to be dead
cases; as gestational age decreased, risk of
death increased (c2 for trend P < .001).
Compared to infants weighing 2500 g
at birth, infants weighing <2500 g at
birth were more likely to be dead cases;
as birthweight decreased, risk of death
increased (c2 for trend P < .001).
Among live-born cases of CS born
at <37 weeks’ gestation, the neonatal
mortality rate of CS was 38.1 per 1000
live births (58 neonatal deaths/1522 live-
born cases of CS born at <37 weeks’
gestation). Among live-born cases of CS
born at <2500 g at birth, the neonatal
mortality rate of CS was 35.2 per 1000
live births (50 neonatal deaths/1419 live-
born cases of CS born at <2500 g at
birth).
Sensitivity analysis to explore
effect of infants of unknown
morbidity
After reclassifying all cases of CS of
unknown morbidity as nonmorbid, the
associations with maternal characteris-
tics and infant characteristics in Table 2
remained unchanged. After reclassify-
ing all cases of CS of unknownmorbidity
as morbid, the RR of delivering a morbid
or dead case among mothers with no
(RR, 3.4) or inadequate (RR, 3.0)
treatment for syphilis (compared to
mothers with adequate treatment) were
reduced, but remained statistically sig-
nificant. There were no other changes in
significance of association.
Comment
Reducing CS (and infant death associ-
ated with it) in the United States remains
a challenge. Overall case fatality ratios
for CS during 1999 through 2013 (6.5%)
and 1992 through 1998 (6.4%)15 were
comparable, as were overall neonatal
mortality rates (11.6 per 1000 live births
during 1999 through 2013, 11.3 per 1000
births during 1992 through 1998).15
Most cases of CS (83%) during 1999
through 2013 still occurred among black
or Hispanic women, with over half of
cases of CS reported from the South
in 2013.14 Almost half of cases of CS
with normal physical examinations (eg,
nonmorbid cases) are infected with CS
based on the presence of treponemal
IgM antibodies18; treatment guidelines
recommend treating infants at risk for,
but without symptoms of, CS.19
Continued efforts to prevent CS are
warranted, including early detection and
treatment of syphilis during pregnancy,
particularly among women of color.
The decreases in rates of dead,
morbid, and nonmorbid cases during
1999 through 2013 (Figure 1) reflect the
decreased overall rate of CS during this
time period.14 Similarly, the racial/ethnic
disparities in rates of dead cases and
morbid cases reported here approximate
the racial/ethnic disparities in the overall
rates of CS in 2013.14 However, the lack
of association between maternal race/
ethnicity of mothers bearing cases of CS
FIGURE 1
Rates of congenital syphilis (CS), by severity of diseaseeUnited States,
1999 through 2013
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In descending order of severity: stillborn infants and infants who died up to 12 months after birth
(dead); infants with strong evidence of syphilis, based on testing indicative of syphilis, physical signs
or symptoms of syphilis, and/or (in mother untreated or inadequately treated for syphilis) elevated
cerebrospinal fluid (CSF) white blood cell count or CSF protein concentration absent other causes
(see “Materials and Methods”) (morbid); infants lacking evidence of infection present in morbid
cases, with normal physical examination reported (nonmorbid); and infants lacking evidence of
infection present in morbid cases, without normal physical examination reported (unknown). Overall,
rates of dead, morbid, and nonmorbid cases of CS all declined during 1999 through 2013. While rate
of dead cases declined slightly and very gradually throughout 1999 through 2013, rates of morbid
and nonmorbid cases declined most during 1999 through 2005.
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and risk of a morbid case or dead case of
CS (Table 2) indicate other characteris-
tics (eg, lack of adequate treatment, low
birthweight) are more strongly associ-
ated with the risk of a morbid or dead
case of CS.
Many maternal and infant character-
istics associated with dead cases of CS
during 1992 through 199815 were asso-
ciated with dead cases of CS during 1999
through 2013 (Table 2). Current guide-
lines recommend aminimum of 10 visits
for prenatal care in a 38-week gesta-
tion.20 The data here demonstrate that
the likelihood of bearing a morbid or
dead case of CS increased as the number
of prenatal visits fell below this mini-
mum (Table 2). Likewise, the likelihood
of bearing a morbid or dead case of
CS increased with inadequate or no
treatment, and with increasing maternal
nontreponemal titer. These observations
underscore the importance of early ac-
cess to prenatal care (ideally during first
trimester), screening of all pregnant
mothers for syphilis early in pregnancy,
and timely and appropriate treatment of
maternal syphilis to prevent infant
morbidity and death from CS.
Extreme prematurity (<28 weeks’
gestation) and extremely low birth-
weight (<1500 g) were the strongest
risks for a dead case of CS among cases of
CS born alive (Table 2). Previous studies
demonstrate that CS is associated with
prematurity and low birthweight in in-
fants.2,21 Controlled studies have shown
that, compared to pregnant women with
nonreactive nontreponemal tests, both
prematurity and reduced birthweight
occurred more frequently in pregnant
women with untreated syphilis22-24;
with appropriate treatment of syphilis
during pregnancy, frequencies of pre-
maturity and reduced birthweight were
comparable to pregnant women with
nonreactive nontreponemal tests.24 The
data here indicate that the likelihood of
death in a live-born infant with CS in-
creases considerably with both the
severity of prematurity and the severity
of reduced birthweight. These data
further highlight the need for detection
and treatment of syphilis early in
pregnancy.
A complex network of overlapping
systems, social structures, and economic
conditions influence population health
outcomes, causing gaps in care.7,9,11,12 In
2009, among 29 states of the United
States, 1 in 4 women delivering an infant
lacked health insurance when they
became pregnant.25 Prenatal care pro-
viders can be unaware of both the (high)
local prevalence of syphilis, and
screening and treatment recommenda-
tions for syphilis.12 Single-parent,
female-headed households are likely to
have young, undereducated mothers,
social and familial instability, gender
power imbalances, and poverty.11 Any
of these factors could complicate
attending prenatal visits, or referral for
treatment.
Prenatal care among mothers bearing
cases of CS is dramatically different from
the norm. In 2010, among all US women
giving birth, 57% had at least 10 prenatal
visits and only 1.2% had no prenatal
care26; 88%of infants were at37weeks’
gestation, and 92% weighed 2500 g at
birth.27 In 2010, the neonatal mortality
rate for infants born in the United States
was 4.1 per 1000 live births.27 In stark
contrast, >20 times as many cases of CS
during 1999 through 2013 had no pre-
natal care, with a neonatal mortality rate
almost 3 times the national rate in 2010
(Table 1). Detecting infection with
syphilis in preconception or early preg-
nancy could avert many cases of, and
most deaths from, CS.
This analysis has limitations.
Because surveillance for CS is a passive
reporting system,14 cases of CS in the
United States might be underreported.
Only 15% of nonmorbid cases had
both CSF and long bone radiographic
examinations. With further laboratory
and radiographic examination, some
nonmorbid cases might have had
positive findings, and been classified as
morbid cases. If laboratory and
radiographic examination is diff-
erentially associated with maternal
or infant characteristics, the estimated
FIGURE 2
Rates of dead cases of congenital syphilis (CS), by race/ethnicity
of mothereUnited States, 1999 through 2013
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Because cases of CS born to non-Hispanic black (black), non-Hispanic white (white), and Hispanic
mothers accounted for 94% of reported cases of CS, this chart focuses on these 3 races/ethnicities.
During 1999 through 2013, rates of dead cases of CS decreased among black mothers and Hispanic
mothers, but remained relatively unchanged among white mothers. In 2013, rate of dead cases of
CS among black mothers and Hispanic mothers was 7.5 and 4.5 times rate among white mothers,
respectively.
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risks associated with morbidity might
be biased. However, the sum of morbid
and nonmorbid cases would remain
unchanged, and risks associated with
infant death would also remain un-
changed. Morbidity was unknown for
377 (6%) cases, but reclassifying all of
these cases as either morbid or non-
morbid led to almost no change in
associated risks. Lastly, case report data
do not include social factors pertinent
to understanding maternal risk and
quality of health care.7,9,11,12
As rates of syphilis among females
approach historic lows, so do rates of CS,
with rates of CS in the United States in
2013 near historic lows.14 Nonetheless,
each CS case is a preventable cause of
infant morbidity and death in the United
States. Detecting and treating pregnant
mothers with syphilis by 21 weeks’
gestation could avert 70% of all mortal-
ity from CS.15 Prenatal and public health
providers in communities with high
rates of CS (and high rates of syphilis
among reproductive-aged women)
should be aware of CS and screen and
treat patients early in pregnancy in
accordance with treatment guidelines.19
Efforts to prevent syphilis among
TABLE 2
Selected demographic and clinical characteristics of infants with congenital syphilis and their mothers
and relative risks, by severity of illnesseUnited States, 1999 through 2013
Maternal characteristics
Morbid and
dead
cases (%)
Nonmorbid
cases (%)
RR (95% CI)
Dead
cases (%)
Morbid and
nonmorbid
cases (%)
RR (95% CI)n ¼ 2563 n ¼ 3443 n ¼ 418 n ¼ 5588
Race/ethnicity
White 300 (12) 377 (11) Ref 38 (9) 639 (11) Ref
Black 1343 (52) 1749 (51) 1.0 (0.9e1.1), P ¼ .676 218 (52) 2874 (51) 1.3 (0.9e1.8), P ¼ .178
Hispanic 783 (31) 1083 (31) 0.9 (0.9e1.0), P ¼ .289 141 (34) 1725 (31) 1.3 (1.0e1.9), P ¼ .090
Asian/Pacific Islander 53 (2) 95 (3) 0.8 (0.6e1.0), P ¼ .058 7 (2) 141 (3) 0.8 (0.4e1.8), P ¼ .668
American Indian/Alaska
Native
31 (1) 33 (1) 1.1 (0.8e1.4), P ¼ .526 5 (1) 59 (1) 1.4 (0.6e3.4), P ¼ .472
Other 10 (0) 27 (1) 0.6 (0.4e1.0), P ¼ .039 1 (0) 36 (1) 0.5 (0.1e3.4), P ¼ .448
Unknown 43 (2) 79 (2) 8 (2) 114 (2)
Prenatal visits, no.
0/No prenatal care 889 (35) 794 (23) 1.5 (1.4e1.7), P < .001 199 (48) 1484 (27) 5.8 (3.6e9.4), P < .001
1e4 461 (18) 551 (16) 1.3 (1.2e1.5), P < .001 84 (20) 928 (17) 4.1 (2.5e6.7), P < .001
5e9 374 (15) 570 (17) 1.2 (1.0e1.3), P ¼ .015 39 (9) 905 (16) 2.0 (1.2e3.5), P ¼ .010
10 302 (12) 583 (17) Ref 18 (4) 867 (16) Ref
Unknown 537 (21) 945 (27) 78 (19) 1404 (25)
Treatmenta
None 1775 (69) 1814 (53) 4.2 (3.5e5.1), P < .001 342 (82) 3247 (58) 8.2 (4.3e15.8), P < .001
Adequate 91 (4) 684 (20) Ref 9 (2) 766 (14) Ref
Inadequate 695 (27) 916 (27) 3.7 (3.0e4.5), P < .001 65 (16) 1546 (28) 3.5 (1.7e6.9), P < .001
Unknown 2 (0) 29 (1) 2 (0) 29 (1)
Nontreponemal titerb
1:4 598 (23) 1273 (37) Ref 45 (11) 1826 (33) Ref
1:8e1:32 990 (39) 1426 (41) 1.3 (1.2e1.4), P < .001 146 (35) 2270 (41) 2.5 (1.8e3.5), P < .001
1:64e1:256 860 (34) 587 (17) 1.9 (1.7e2.0), P < .001 200 (48) 1247 (22) 5.7 (4.2e7.9), P < .001
>1:256 101 (4) 123 (4) 1.4 (1.2e1.7), P < .001 25 (6) 199 (4) 4.6 (2.9e7.4), P < .001
Unknown 14 (1) 34 (1) 2 (0) 46 (1)
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women, particularly of reproductive age,
should continue. Local barriers to
accessing quality prenatal care (eg, early
screening and treatment for syphilis),
and to broader sexually transmitted
disease and reproductive health in-
terventions, should be identified and
addressed in these same communities.n
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